Division of Infectious Diseases, Department
of Medicine, University of Maryland School of Medicine, Baltimore,
Maryland 21201
 |
INTRODUCTION |
Bundle-forming pili (BFP) are type
IV fimbriae expressed by enteropathogenic Escherichia coli
(EPEC), a bacterium that causes infantile diarrhea (25).
BFP are a demonstrated EPEC virulence factor (6) and can
elicit an immune response in naturally occurring infections
(40). The presence of BFP is required for two notable EPEC
phenotypes. Localized adherence, the classical phenotype, describes the
binding of EPEC to cultured epithelial cells in a characteristic
clustered formation (56). A similar pattern has been noted
in EPEC infections in vivo (52). Autoaggregation, the
second phenotype, describes the formation of dynamic
multicellular clusters of EPEC grown in tissue culture
medium (6). The relevance of this phenomenon to EPEC
infection of the human intestinal tract is unclear.
Few details are known about the molecular mechanisms of type IV
fimbrial biogenesis. Our current concept of BFP synthesis is as follows
(21). BFP fibers are polymers of a pilin protein known as
bundlin. Coincident with or following their synthesis, bundlin
precursors are probably anchored in the cytoplasmic membrane (via a
stretch of hydrophobic residues located near their N termini), with the
majority of the polypeptide being exported to the periplasm. On the
cytoplasmic side of the membrane, the N-terminal leader peptide of
prebundlin is removed by the BfpP prepilin peptidase (75).
In the periplasm, the formation of a disulfide bond required for
bundlin stability is catalyzed by the oxidant DsbA (74). Following these events, the modified bundlin monomers are somehow removed from the membrane and polymerized into fimbriae that are extruded through the outer membrane.
BFP biogenesis is dependent on a cluster of 14 bfp genes
located on a large plasmid found in many EPEC strains (58,
60). Expression of these 14 genes in a K-12 laboratory strain of
E. coli that is normally nonpiliated is sufficient to elicit
BFP formation (60). The bfpA gene encodes
prebundlin (17, 57), while the bfpP gene
encodes the prepilin peptidase (4, 75). A third gene,
bfpB, encodes an outer membrane lipoprotein that is
a member of the secretin family and is required for BFP biogenesis (4, 49). The bfpF gene encodes a putative
cytoplasmic membrane protein that is not essential for BFP biogenesis
but is required for the dynamic behavior of EPEC autoaggregates and BFP
bundles (3, 6, 33). The precise functions of the 10 remaining bfp gene products are unknown. At least four of
them (bfpC, bfpD, bfpG, and bfpL) are required
for BFP biogenesis, while bfpH is not (4, 6, 58,
60). The seventh gene in the bfp cluster, bfpE, encodes a putative polytopic cytoplasmic
membrane protein, BfpE, which has been detected using inducible T7 RNA
polymerase expression systems (58, 60). BfpE is a member
of the GspF family of proteins, which includes components of other
systems that transport macromolecules or macromolecular assemblies
(including type IV pili) across bacterial envelopes (48,
53). In this report, we describe preliminary analyses of the
function and structure of BfpE.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
The E. coli strains used in this study are listed in Table
1. Strains were routinely cultured in
Luria-Bertani (LB) broth or on LB agar at 37°C. Antibiotics and/or
chromogenic substrates were added as necessary at the following
concentrations: ampicillin, 200 µg/ml; chloramphenicol, 20 µg/ml;
nalidixic acid, 50 µg/ml; kanamycin, 50 µg/ml;
5-bromo-4-chloro-3-indolylphosphate (BCIP), 40 µg/ml;
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal), 40 µg/ml. Dual-indicator plates were prepared as described elsewhere (1).
Autoaggregation assay.
EPEC strains were cultured overnight
at 37°C in LB (plus ampicillin as appropriate). The resulting
stationary-phase cultures were diluted 1:100 or 1:250 (making
adjustments for the optical density at 600 nm [OD600])
into 20 ml of Dulbecco's modified Eagle medium plus nutrient mixture
F-12 (DMEM/F-12) containing 15 mM HEPES buffer and lacking phenol red
(Gibco-BRL Life Technologies no. 11039-021). The DMEM/F-12 cultures
were shaken at 250 rpm for 5 h in 50-ml conical polypropylene
tubes at 37°C. Autoaggregation was gauged by visually inspecting the
cultures for bacterial aggregates and sedimentation, by examining
5-µl aliquots of the culture under phase-contrast microscopy, and by
determining the aggregation index (AI) (4). To determine
AI, two equivalent 1-ml samples were removed from each culture. The
OD600 of the first sample was measured immediately using a
spectrophotometer. The second sample was agitated for 1 min on a vortex
mixer before the OD600 was measured. AI was calculated by
subtracting the OD600 of the first sample from that of the
second, dividing the result by the value of the first sample, and
multiplying by 100.
Localized adherence assay.
Localized adherence to HEp-2
laryngeal carcinoma cells was assayed as described previously
(19), using the eight-well chamber slide modification.
Transmission electron microscopy.
To prepare samples for
electron microscopy, 1-ml aliquots were removed from EPEC cultures
grown in DMEM for 6 h and the bacteria were pelleted by brief
centrifugation. Most of the medium was decanted, and the bacterial
pellet was gently resuspended in the remainder. A 10-µl aliquot was
spotted onto electron microscopy grids, which were dried for 10 min and
then stained and examined as described previously (3, 60).
Sequence analysis.
Eight computer programs available on the
Internet were used to examine the BfpE protein sequence for the
presence of hydrophobic regions having the potential to be
transmembrane (TM) segments. These programs are DAS
(13) (http://www.sbc.su.se/~miklos/DAS/), HMMTOP
(65) (www.enzim.hu/hmmtop/), PHDhtm/PHDtopology (50, 51) (www.embl-heidelberg.de/predictprotein/), PSORT (43) (http://psort.nibb.ac.jp/), SOSUI (29) (http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0.html), TMHMM (59) (www.cbs.dtu.dk/services/TMHMM-1.0/), TMpred (30) (www.isrec.isb-sib.ch/software/TMPRED_form.html), and TopPred2 (12, 68)
(http://www.sbc.su.se /~erikw/toppred2/). Five of these
programs (HMMTOP, PHDtopology, TMHMM, TMpred, and TopPred2) were
also used to predict the membrane topology of BfpE.
Plasmids, primers, PCR, and sequencing.
Source plasmids used
for this study are listed in Table 2. The
plasmids constructed during the course of this work are described below. Oligonucleotide primers used for PCR and plasmid sequencing are
listed in Table 3. The University of
Maryland School of Medicine Biopolymer Laboratory performed all primer
syntheses as well as plasmid sequencing. Standard techniques were used
for DNA manipulation (54). Plasmids were maintained in
strain DH5
or CC118 and were prepared using the Wizard Plus SV
Minipreps DNA Purification System (Promega). PCR was carried out using
Taq (Gibco-BRL) or Pfu (Stratagene) polymerase as
specified by the manufacturer.
Construction of strain UMD934 containing a nonpolar
bfpE mutation.
A previously described allelic
replacement strategy (20) was modified to disrupt the
bfpE gene in wild-type EPEC strain E2348/69. Plasmid pHZZ4B1
was linearized at a unique AflIII site specified by codons
130 and 131 of bfpE and then treated with Klenow fragment of
DNA polymerase I. The blunted ends were ligated to the 850-bp
SmaI fragment from pUC18K carrying the nonpolar aphA-3 cassette specifying kanamycin resistance
(41), creating pTEB43-K1A. Restriction analysis followed
by sequencing using the Donne-200 primer confirmed that the
aphA-3 gene was inserted in the same orientation as
bfpE and was in the proper reading frame to reinitiate
translation from the 3' end of the transcribed cassette. Plasmid
pTEB43-K1A and suicide vector pCVD442 were both digested with
SalI and then ligated to form pTEB44, in which the bfpE::aphA-3 and sacB genes
are transcribed in opposite orientations. Plasmid pTEB44 was next
digested with SacI to remove a 5.9-kb fragment containing
the pACYC184 origin of replication, chloramphenicol resistance gene,
and a portion of the bfp cluster. The remaining 9.3-kb
SacI fragment was religated to form the
bfpE::aphA-3 suicide plasmid pTEB45,
which was introduced into DH5
pir by electroporation. HB101 containing helper plasmid pRK2073 was used to mobilize pTEB45 from DH5
pir into EPEC strain E2348/69. EPEC
transconjugants were selected on LB plates containing nalidixic acid
and kanamycin. From among these, an isolate was identified that was
resistant to kanamycin and 5% sucrose but sensitive to ampicillin.
Replacement of the wild-type bfpE allele by the
bfpE::aphA-3 allele in this strain, UMD934,
was confirmed by PCR analysis using primers Donne-243 and Donne-256.
Construction of plasmids for membrane topology analysis.
A
matched set of plasmids for membrane topology analysis was derived from
the low-copy expression vector pTrc99A (Amersham Pharmacia Biotech).
One plasmid, pTrcphoA, carries the 'phoA gene (lacking
codons Met 1 through Met 26 encoding the signal sequence), while the
other, pTrclacZ, carries the 'lacZ gene (lacking codons Met
1 through Ser 7). To construct pTrcphoA, overlap extension PCR was
first used to eliminate the NcoI site from 'phoA.
Specifically, a portion of 'phoA upstream of and overlapping
the NcoI site was amplified using primers Donne-222 and
Donne-224, with plasmid pCVD433::31TnphoA as the template. A second
portion of 'phoA overlapping and downstream of the
NcoI site was prepared using primers Donne-211 and
Donne-223. The two portions were annealed and amplified with primers
Donne-224 and Donne-211, creating a 'phoA fragment carrying a silent mutation of CAT to CAC at histidine codon 272. The ends of the
'phoA fragment were digested with BamHI and
KpnI and inserted into the multiple-cloning site of
BamHI-KpnI-digested pTrc99A. To construct
pTrclacZ, the 'lacZ gene was amplified by PCR using Donne-227 and Donne-228 as primers and pMD103 as template. The ends of
the 'lacZ PCR product were digested with BamHI
and KpnI and then ligated to
BamHI-KpnI-digested pTrc99A. In both pTrclacZ and
pTrcphoA, the reporter genes are fused in frame to a start codon
directly downstream of the trc promoter. Fusion genes can be
created in these plasmids by inserting gene segments between restriction sites present between the start codon and reporter gene.
Construction of random bfpE'::'phoA
and bfpE'::'lacZ gene fusions.
PCR
using primers Donn-243 and Donne-256 and pKDS135 as template was used
to construct the bfpE355 allele, which differs slightly from
wild-type bfpE at both ends. At the 5' end of the PCR
product, the initiator Met codon (Met-1) was replaced with a sequence
creating an NcoI site and an extra Ala codon between Met-1
and Lys-2. At the 3' end of PCR product, the TGA termination codon was
replaced with a sequence encoding Leu-Glu-STOP and multiple restriction sites. The bfpE355 PCR product was digested with
NcoI and XmaI and ligated to the large fragments
of pTrcphoA and pTrclacZ resulting from digestion with the same
enzymes, creating pTEB41 and pTEB42. In both plasmids, the
bfpE355 gene is followed by a TAA termination codon and a
13-bp linker sequence, rendering the 'lacZ or
'phoA genes out of frame. Plasmid pTEB65 carrying
bfpE but no reporter gene was constructed by deleting a
1.36-kb NheI-XbaI fragment containing
'phoA from pTEB41.
The Erase-a-Base system (Promega) for exonuclease III digestion
(28) was used to generate 3' deletion derivatives of the bfpE gene. Both pTEB41 and pTEB42 were linearized at the
NheI site located between bfpE and
'lacZ or 'phoA. The NheI ends were filled in with
-phosphorothioates using Klenow DNA polymerase to
protect the 'phoA or 'lacZ reporter genes from
digestion. The linearized plasmids were next digested with
XhoI to expose a 5' overhang adjacent to bfpE355.
Exonuclease III was added, and the digests were incubated at room
temperature for 6 to 8 min. Samples were removed at 30-s or 1-min
intervals; treated sequentially with S1 nuclease, Klenow, and T4 DNA
ligase; and then used to transform strain DH5
, which was plated on
media containing ampicillin and BCIP or X-Gal. Dark blue colonies were
cultured, and plasmids were prepared from isolates that continued to
exhibit the dark blue color after replating. To determine the
approximate size of the partial bfpE segments, plasmids
containing bfpE'::'lacZ fusions were analyzed
by digestion with EcoRV, NcoI, XhoII,
XmaI, and XmnI, and plasmids containing
bfpE'::'phoA fusions were analyzed by PCR
using primers Donne-243 and Donne-272. Sequencing of selected plasmids
was carried out using primers Donne-272 (annealing to phoA)
and Donne-273 (annealing to lacZ) to determine the precise location of the bfpE fusion junction. Most of the
bfpE' alleles are separated from the 'lacZ or
'phoA genes by a linker sequence (GCACCCGGG) that
encodes Ala-Pro-Gly and contains an AvaI site allowing the
bfpE' allele to be subcloned into another context. The
exceptions are bfpE352, which is followed by a linker
sequence (CCACCCGGG) encoding Pro-Pro-Gly, and
bfpE149', which is fused directly to 'phoA.
Construction of specific bfpE'::'phoA
and bfpE'::'lacZ fusions.
The randomly
generated bfpE' alleles described above were transferred as
NcoI-AvaI fragments to the vector (pTrcphoA
digested with NcoI-AvaI, or pTrclacZ digested
with NcoI-XmaI) containing the complementary
reporter gene. PCR was used to construct additional plasmids containing
bfpE' segments of specified sizes. Each of the PCR
amplifications used pTEB65 as template and Donne-243 as the upstream
primer. The downstream primers were Donne-305, Donne-316, Donne-317,
Donne-318, and Donne-319. PCR products containing bfpE' segments were digested with NcoI and AvaI and
introduced into pTrcphoA digested with NcoI-AvaI
or into pTrclacZ digested with NcoI-XmaI.
Construction of internal deletions in bfpE.
Three plasmids carrying bfpE::'phoA fusions
containing internal deletions in bfpE were constructed by
introducing downstream segments of bfpE into existing
bfpE'::'phoA fusion plasmids. To construct
the bfpE292'
(210-233)::'phoA plasmid,
primers Donne-343 and Donne-344 were used to amplify a fragment from
the bfpE292'::'phoA plasmid containing codons
234 through 292 of bfpE plus the proximal end of
'phoA. The resulting 722-bp PCR product was digested with NgoMIV and RsrII and then introduced into the
bfpE78'::'phoA plasmid that had been digested
with AvaI and RsrII. To construct the
bfpE352
(116-301)::'phoA plasmid, primers
Donne-315 and Donne-344 were used to amplify a fragment from the
bfpE352::'phoA plasmid containing codons 302 through 352 of bfpE plus the proximal end of
'phoA. The resulting 697-bp PCR product was digested with
NgoMIV and RsrII and then introduced into the
bfpE115'::'phoA plasmid that had been
digested with AvaI and RsrII. To construct the
bfpE352
(210-233)::'phoA plasmid, primers
Donne-222 and Donne-343 were used to amplify a fragment from the
bfpE352::'phoA plasmid containing codons 234 through 352 of bfpE plus the proximal end of
'phoA. The resulting 1,202-bp PCR product was digested with
NgoMIV and RsrII and then introduced into the
bfpE209'::'phoA plasmid that had been
digested with AvaI and RsrII. A linker sequence
specifying Ala-Pro-Gly replaced the deleted bfpE codons in
each of the new plasmids. A plasmid carrying bfpE with a
deletion of sequences specifying HS3 was constructed by replacing an
NcoI-EcoO109I fragment of pTEB65 with the
corresponding fragment from the
bfpE352
(210-233)::'phoA plasmid.
Construction of
bfpE'::'phoA-lacZ
::'bfpE
sandwich fusions.
Sandwich fusion plasmids were constructed by
in-frame insertion of a dual-reporter 'phoA-lacZ
cassette
from pMA632 into unique restriction sites within the bfpE
gene of pTEB65. The cassette was inserted into the BtrI site
as a SmaI-EcoRV fragment. The cassette was
amplified from pMA632 by PCR using primers Donne-383 and Donne-384, cut
with AvaI, and inserted into the BspEI site. Likewise, the cassette was amplified using primers Donne-385 and 386, cut with EcoO109I, and then inserted into the
EcoO109I sites of both pTEB65 and its
HS3 derivative. A
plasmid carrying a tandem repeat of the cassette at the
EcoO109I site of the full-length bfpE gene was a
by-product of this construction. The cassette was inserted into the
filled-in AvaI site as a SmaI-NruI
fragment. The NcoI site in the phoA gene of the
AvaI insertion plasmid was eliminated by replacing a 331-bp
EcoRI fragment with the corresponding fragment from
pTrcphoA, generating pTEB120. Digestion of pTEB120 with NcoI
and AvaI or XhoI will precisely remove the
bfpE gene, allowing any gene fragments to be placed there to
construct novel C-terminal dual-reporter fusions.
Construction of bfpE derivatives with a C-terminal
epitope tag.
The full-length bfpE gene (codons 1 to
352) was amplified by PCR from pTEB65 using primers Donne-243 and
Donne-507, digested with NcoI and XbaI, and
inserted into the corresponding sites in the multiple-cloning site of
pBAD/myc-His B. Partial bfpE genes were amplified
using primers Donne-486 and Donne-507 (codons 234 to 352) or primers
Donne-486 and Donne-508 (codons 234 to 323), digested with
NcoI and XbaI, and inserted into the
corresponding sites in the multiple-cloning site of pBAD/gIII A.
Immunoblotting.
For the bundlin immunoblot, overnight LB
broth cultures of EPEC were diluted 1:100 into 20 ml of DMEM/F-12.
After 6 h of growth at 37°C with shaking, the bacteria were
pelleted by centrifugation at 2,500 × g for 10 min and
then resuspended in 1.2 ml of cell lysis buffer (20 mM Tris-HCl [pH
8.0], 500 mM NaCl, 0.1 mM EDTA, 0.1% Triton X-100). The remaining
procedures for sample preparation, protein concentration measurement,
and electrophoresis were as previously described (4). The
blots were blocked with phosphate-buffered saline containing 0.1%
Tween-20 plus 5% nonfat dry milk and then incubated sequentially with
a 1:10,000 dilution of ICA4, a monoclonal immunoglobulin G1 antibody
raised against BFP (26), with an anti-mouse horseradish
peroxidase (HRP) conjugate at a 1:30,000 dilution, and, finally, with
enhanced chemiluminescence (ECL) Western blotting detection reagents
(Amersham Pharmacia Biotech).
For immunoblots of BfpE-PhoA and BfpE-LacZ fusions, overnight cultures
of CC118 plus the appropriate plasmids were diluted 1:20 into LB broth
containing ampicillin and, for BfpE-LacZ fusions only, 0.2% glucose.
Cultures were grown to an OD600 between 0.3 and 1.0. Aliquots (1 ml) were centrifuged in a microcentrifuge for 3 min, and
the bacterial pellets were washed once with 1 ml of 1 M Tris-HCl (pH
8.0) and then resuspended in 1 ml of cell lysis buffer. The
OD620s of the samples were determined using a Titertek
Multiskan MCC microtiter plate reader. To prepare samples for
electrophoresis, 25 µl of 4× sodium dodecyl sulfate (SDS) loading
buffer (17) was added to 150 µl of bacterial
suspensions, which had been diluted based on the OD620
readings. Samples of 25 µl (BfpE-PhoA fusions) or 10 µl (BfpE-LacZ
fusions) were separated by SDS-polyacrylamide gel electrophoresis
(PAGE), transferred to Immobilon-P polyvinylidene difluoride membranes
(Millipore), and blocked as described above. To detect BfpE-PhoA
fusions, blots were incubated sequentially with a 1:2,000 dilution of
antibacterial alkaline phosphatase antibody (5 Prime
3 Prime Inc.),
with a 1:30,000 dilution of anti-rabbit HRP conjugate (Amersham
Pharmacia Biotech), and then with ECL detection reagents. To detect
BfpE-LacZ fusions, blots were incubated sequentially with
anti-
-galactosidase antibody (5 Prime
3 Prime Inc.) at a 1:4,000
dilution, with anti-rabbit HRP conjugate at a 1:40,000 dilution, and
then with ECL Plus Western blotting detection reagents. To detect
proteins carrying the myc-His epitope tag, blots were
incubated with an anti-His(C-term)-HRP conjugate antibody (Invitrogen).
Enzyme assays.
To assay the enzyme activities of BfpE-PhoA
fusions, cultures were grown as described above for immunoblotting.
Samples were prepared and alkaline phosphatase assays were carried out
by a microtiter plate procedure described previously (14),
with the following modifications. The volume of diluted, permeabilized cultures added to the wells of the microtiter plate was 220 µl, and
the volume of para-nitrophenyl phosphate solution was 20 µl. After a 15-min incubation at room temperature, the reactions were stopped by adding 20 µl of 1 M KH2PO4 plus 4 µl of 0.5 M EDTA (pH 8.0) to each well. OD readings were recorded at
620 nm (cell density), 414 nm (yellow color), and 540 nm (light
scattering by cell debris). To assay the activities of BfpE-LacZ
C-terminal fusions,
-galactosidase assays were carried out in a
similar fashion, with the following modifications. Bacteria from 1-ml culture samples were pelleted, washed with 1 ml of 1 M Tris-HCl (pH
8.0), and resuspended in 1 ml of Z buffer (42). Aliquots of cultures that had been diluted 1:4 or 1:9 in Z buffer and then permeabilized were placed in the wells of a microtiter plate. The
reaction was started by adding 37.5 µl of 10-mg/ml
ortho-nitrophenyl-
-D-galactoside (ONPG)
prepared in Z buffer and allowed to continue for 20 min at room
temperature. The reactions were stopped by adding 75 µl of 1 M
Na2CO3. Activity units were calculated by
standard methods (37, 42), with appropriate adjustments
for the dilution of the original cultures. The
-galactosidase
activities of the BfpE-dual-reporter sandwich fusions could not be
detected using ONPG. They were detectable using the more sensitive
fluorescent substrate
4-methylumbelliferyl-
-D-galactoside (MUG). The MUG assay
was carried out as described previously (42), except that
a Shimadzu fluorescence spectrophotometer was utilized. A standard
curve of 12.5 to 400 pM 4-methylumbelliferone was used as a reference
to calculate units of specific
-galactosidase activity
(42).
Sucrose density flotation gradient fractionation.
TOP10
strains containing plasmids with epitope-tagged bfpE
derivatives were grown overnight in LB medium, diluted 1:100 into 30 ml
of fresh LB medium, and shaken at 37°C for 4 h, after which arabinose was added to 0.2% to induce protein expression and shaking was continued for an additional 3 h. The remainder of the
procedure was performed as previously described (4).
 |
RESULTS |
Phenotypes of a bfpE mutant.
To determine whether
the bfpE gene product plays a role in BFP biogenesis and
BFP-associated phenotypes, we constructed UMD934, an EPEC strain
containing a nonpolar insertion mutation in the bfpE gene.
UMD934 was examined for BFP formation directly by transmission electron
microscopy and indirectly by assaying for the BFP-dependent phenomena
of autoaggregation and localized adherence. The isogenic wild-type EPEC
strain E2348/69 and the bfpA mutant strain UMD901 were
included in these experiments as positive and negative controls, respectively. BFP were readily detected emanating from cells of strain E2348/69 (Fig. 1A) but were
not detected on cells of strain UMD901 or UMD934. When E2348/69 was
grown in DMEM/F-12 tissue culture medium for at least 3 h,
visible bacterial aggregates formed (Fig. 1D). In contrast,
UMD901 and UMD934 cultures did not develop visible or even
microscopic aggregates. To quantify the extent of autoaggregation
in these strains, an AI was calculated. AI is a measure of the
percent increase in OD that occurs after agitation of the culture to
disperse bacterial aggregates (3, 4). E2348/69 exhibited a
high AI value, while the bfpE mutant UMD934 exhibited a low
AI value similar to that of UMD901 (Table 4). When tested for localized adherence
to HEp-2 epithelial cells in tissue culture, E2348/69 exhibited
the characteristic clustered pattern (Fig. 1G). UMD901 and UMD934
adhered poorly. To determine whether BfpE plays a role in bundlin
expression and processing, extracts of EPEC strains were subjected to
immunoblotting using an anti-bundlin antibody. UMD934 was found to
produce completely processed bundlin at normal levels (Fig.
2).

View larger version (135K):
[in this window]
[in a new window]
|
FIG. 1.
Assay of BFP formation, autoaggregation, and localized
adherence by EPEC. Shown are the wild-type EPEC strain E2348/69 (A, D,
and G) and the isogenic bfpE mutant UMD934 bearing either
the vector pTrcphoA (B, E, and H) or plasmid pTEB41 carrying the
bfpE gene (C, F, and I). The top row (A to C) displays
transmission electron micrographs of EPEC cultured in DMEM for 6 h. Magnifications, ×20,000 (A) and ×12,000 (B and C). Bar, 200 nm (A)
or 500 nm (B and C). BFP can be seen in panels A and C. The center row
(D to F) displays phase-contrast micrographs (magnifications,
approximately ×460 for panels D and F and ×580 for panel E) of EPEC
cultured in DMEM for 7 h and then examined in hanging drop slides. EPEC
aggregates are seen in panels D and F. The bottom row (G to I) displays
phase-contrast micrographs (magnification, ×630) of HEp-2 cells
incubated for 3 hours with EPEC, washed, and fixed. Adherent EPEC
microcolonies are seen in panels G and I. Arrows point to two of the
microcolonies in each panel.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Examination of bundlin expression and processing
by EPEC. Whole-cell extracts were prepared from EPEC
strains (left to right) E2348/69, UMD932, UMD901, UMD934, E2348/69
(pTrcphoA), UMD934 (pTrcphoA), and UMD934 (pTEB41) after growth
in DMEM/F-12 for 6 h. Extracts were separated by SDS-PAGE
using a 15% polyacrylamide gel. A monoclonal antibody was used to
detect bundlin.
|
|
Complementation of the bfpE mutation.
The low-copy
plasmid pTEB41, which carries the cloned bfpE gene, was
introduced into strain UMD934 to complement the bfpE mutation. UMD934 bearing pTEB41 exhibited BFP formation,
autoaggregation, and localized adherence (Fig. 1C, G, and I; Table 4),
while UMD934 bearing the control vector pTrcphoA did not (Fig. 1B, E,
and H; Table 4). These results demonstrated conclusively that
bfpE is required for BFP biogenesis. In pTEB41, a pTrc99A
derivative, the bfpE gene is expressed under the control of
the trc promoter. This promoter is supposed to be
efficiently repressed by the product of the
lacIq gene present on the plasmid and can be
derepressed by the addition of
isopropyl-
-D-thiogalactopyranoside (IPTG)
(2). However, successful complementation of the
bfpE mutant did not require the addition of IPTG. The
repressed level of bfpE expression from pTrc99A derivatives
was sufficient not only for complementation but also for the production
of BfpE fusion proteins at a level that can be readily detected by
immunoblotting and enzyme assays (see below).
Predictions of BfpE topology and TM segments.
Hydropathy plots
and computer programs were used to identify potential TM segments in
BfpE and to suggest the most likely topology of the protein (see
Materials and Methods). Four hydrophobic segments potentially
long enough to span the cytoplasmic membrane were identified
by all programs. These segments, designated HS1 through HS4, are
located at residues 115 to 139, 171 to 191, 212 to 232, and 322 to 342, respectively, of BfpE (modal values from eight programs). In the
predominant topology model (predicted by three of five programs), all
four of the hydrophobic segments cross the membrane and both termini of
the protein are found in the cytoplasm.
Construction of random and specific
bfpE'::'phoA and
bfpE'::'lacZ fusions.
To
determine the topology of BfpE experimentally, we turned to the
construction and analysis of bfpE'::'lacZ and
bfpE'::'phoA fusions. Such fusions are
commonly used to study membrane protein topology (reviewed in
references 37, 48, 64, and 66). Enzymatically active
-galactosidase (LacZ) fusions are expected to identify regions of
BfpE that reside in the cytoplasm, while active alkaline phosphatase
(PhoA) fusions are expected to identify regions of BfpE that reside in
the periplasm. The bfpE gene was introduced into the
expression vector pTrc99A upstream from and out of frame with
'lacZ or 'phoA reporter genes. Exonuclease III was used to degrade the bfpE gene from the 3' end and create
a nested set of bfpE' C-terminal deletion fusions to
'phoA or 'lacZ. The plasmid pool carrying these
gene fusions was introduced into E. coli DH5
.
Colonies containing enzymatically active BfpE-LacZ and
BfpE-PhoA fusions were identified on medium containing the chromogenic substrates X-Gal or BCIP.
To identify active in-frame fusions of bfpE' to
'phoA, plasmids were isolated from 58 colonies that
exhibited a dark blue color on medium containing BCIP. All plasmids
were analyzed to determine the relative lengths of their partial
bfpE genes. Twenty plasmids were selected for sequencing to
determine the precise location of the fusion junction. All of these
carried in-frame gene fusions, and 15 unique bfpE' endpoints
were identified among them. Most of the
bfpE'::'phoA fusions specified proteins in
which the BfpE endpoint was located in a relatively hydrophilic segment or at the margins of a putative TM segment. No endpoints were located
in the N-terminal hydrophilic segment of BfpE. Three endpoints (Thr
139, Leu 149, and Ala 157) were located between candidate TM segments
HS1 and HS2. Two endpoints (at Leu 190 and Trp193) were near the end of
HS2, and seven (at Trp 246, Trp 249, Glu 267, Asn 270, Ile 282, Gly
292, and Leu 320) were between HS3 and HS4. One endpoint was near the
end of HS4 (Ser 337), while two were C-terminal to HS4 (Ala 349 and Phe 352).
To identify active fusions of bfpE' to 'lacZ, we
prepared plasmids from 55 colonies that exhibited a dark blue color on
medium containing X-Gal. This screen was complicated by the fact that colonies containing pTEB42 itself generally exhibited a light blue
color on X-Gal. Despite the presence of a stop codon and frameshift and
the absence of an initiation codon between the bfpE and
lacZ genes on this plasmid, pTEB42 is capable of expressing a
-galactosidase-sized protein (Fig.
3) having detectable enzyme activity
(1,780 ± 48 U). We do not know the mechanism by which such a
protein is produced. Despite this complication, restriction analysis
and sequencing of plasmids led to the identification of one in-frame
bfpE'::'lacZ fusion gene, specifying a
protein having a BfpE endpoint at Leu 36.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 3.
Expression of BfpE-LacZ fusion proteins. Whole-cell
extracts were prepared from plasmid-bearing derivatives of E. coli CC118 and separated by SDS-PAGE on a 6% polyacrylamide gel.
The fusion proteins were detected with an anti- -galactosidase
antibody. The positions of molecular mass markers are displayed to the
left of the blot. The first three lanes display samples from strains
carrying control plasmids pTEB65 (no LacZ), pTrclacZ (no BfpE), and
pTEB42 (substrate for exonuclease III digestion). The remaining lanes
display samples from strains carrying plasmids with
bfpE'::'lacZ fusion genes. The number of the terminal
amino acid in the BfpE portion of the fusion protein is noted above
each lane. The arrow to the right of the blot indicates a prominent
degradation product of many of the fusions that is similar in size to
-galactosidase (LacZ).
|
|
The bfpE' segments from most of the random 'lacZ
and 'phoA fusions described above were transferred by
cloning into the alternate vector (pTrcphoA or pTrclacZ) so that they
could be analyzed in the context of both reporter genes. It was
expected that LacZ and PhoA fusion proteins having identical BfpE
segments would exhibit complementary activities. Plasmids carrying
additional bfpE'::'lacZ or
bfpE'::'phoA fusions were constructed by PCR
amplification of specific bfpE' segments. These constructs,
designed to supplement the randomly generated fusions at critical
points, specified fusion proteins with BfpE endpoints at Trp 78, Gly
115, Phe 201, Ile 209, or Val 323. The entire set of constructs is
depicted in Fig. 4.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 4.
Activities of BfpE-LacZ and BfpE-PhoA fusion proteins.
In the diagrams to the left, the shaded bars represent the extent of
BfpE included in each fusion protein and the black boxes represent
potential transmembrane segments. Black lines and triangles indicate
deleted portions of BfpE. Alkaline phosphatase or -galactosidase
enzyme assays were performed on permeabilized cultures of E. coli CC118 carrying fusion plasmids. The bar graph data represent
the mean and standard error values (in units of enzyme activity) for
four enzyme activity determinations from a single set of permeabilized
cells per sample. Similar results were obtained in repeated
experiments. Each datum point corresponds to the fusion depicted to the
left of it. Four points are absent from the LacZ data (indicated by
asterisks) because a plasmid expressing the fusion was not constructed
(residue 149) or a fusion protein was not detected by immunoblotting
(residues 157, 249, and 352).
|
|
Analyses of fusion protein enzyme activity and expression.
To
indicate a cytoplasmic or periplasmic location for the reporter
enzyme moieties of the BfpE fusion proteins, alkaline phosphatase or
-galactosidase activities were determined for permeabilized E. coli CC118 bearing bfpE'::'phoA or
bfpE'::'lacZ plasmids (Fig. 4). To determine
whether BfpE-LacZ and BfpE-PhoA fusion proteins were expressed,
whole-cell extracts were prepared from these strains and subjected to
immunoblotting using anti-LacZ and anti-PhoA antiserum (Fig. 3 and
5).

View larger version (73K):
[in this window]
[in a new window]
|
FIG. 5.
Expression of BfpE-PhoA fusion proteins. Whole-cell
extracts were prepared from plasmid-bearing derivatives of E. coli CC118 and separated by SDS-PAGE on a 6.5% polyacrylamide
gel. The fusion proteins were detected with an anti-PhoA antibody. The
positions of molecular mass markers are displayed to the left of the
blot. The first three lanes display samples from strains carrying
control plasmids pTrcphoA (no BfpE), pTEB41, and pTEB65 (no PhoA). The
remaining lanes display samples from strains carrying plasmids with
bfpE'::'phoA fusion genes. The number of the terminal
amino acid in the BfpE portion of the fusion protein is noted above
each lane. The arrow to the right of the blot indicates a prominent
degradation product of many of the fusions that is similar in size to
alkaline phosphatase (PhoA).
|
|
The BfpE-PhoA fusions produced a reasonably clear picture of the
topology of most of BfpE. All bfpE'::'phoA
fusions produced readily detectable proteins (Fig. 5). As expected, the
fusion protein size increased with the length of the BfpE segment
included. The three PhoA fusions having BfpE endpoints located before
HS1 (at residues 36, 78, and 115) had no or low alkaline phosphatase activities, indicating a cytoplasmic location (Fig. 4). PhoA fusions having BfpE endpoints between HS1 and HS2 (at residues 139, 149, and
157) exhibited particularly high activities, indicating a periplasmic location. Two randomly generated PhoA fusions located between HS2 and HS3 (at residues 190 and 193) exhibited low activities. These fusions contain none or only one of the five positively charged
residues that are found between HS2 and HS3. Two other fusions
constructed at residues 201 and 209 contain three or four positively
charged residues downstream of HS2. These fusions had no alkaline
phosphatase activity. These findings are in accord with previous data
demonstrating that positive charges can promote cytoplasmic
localization (7) and indicate that the region of BfpE
between HS2 and HS3 is located in the cytoplasm. Fusions between HS3
and HS4 (at residues 246, 249, 267, 270, 282, 292, 320, and 323) had
moderately high activities, suggesting a periplasmic location. The
BfpE-PhoA fusion results up to HS4 are completely consistent with a
BfpE topology in which the N terminus is located in the cytoplasm and
HS1, HS2, and HS3 act as TM segments. It was expected that HS4 would
also cross the membrane, leading to low PhoA activities in the fusions
downstream. PhoA fusions at BfpE residues 337 and 349 had rather low
activities. These data were difficult to interpret, however, because
fusions at these points (and at residues 320 and 323) exhibit reduced
amounts of fusion protein. In contrast, a fusion of full-length BfpE
(residue 352) to PhoA had strikingly high activity and a high protein
level. These results suggested that HS4, the final hydrophobic segment of BfpE, does not act as a TM segment. A second interpretation could be
that while both HS3 and HS4 may be capable of spanning the membrane
independently, HS3 is excluded from the membrane in the presence of HS4.
Many of the BfpE-PhoA fusion proteins appeared to be subject to
degradation, producing a prominent protein having an electrophoretic mobility similar to that expected for processed alkaline phosphatase (~47 kDa) (Fig. 5). Similar degradation products have been noted previously in other phoA-based topology studies (8,
24, 27, 39). They are thought to result from the action of a
periplasmic protease that releases a properly folded PhoA moiety
from the fusion protein. Therefore, the appearance of these degradation products may be a useful indicator of PhoA export. Accordingly, PhoA-sized degradation products were present in samples of all BfpE-PhoA fusions having moderate to high enzyme activity. Such degradation products were absent or scarce in samples of most of the
low-activity fusions (especially those having BfpE endpoints at
residues 36, 78, 115, 193, 201, and 209).
Four problems were encountered with the BfpE-LacZ fusions. First, four
important BfpE-LacZ fusions having endpoints corresponding to those of
the PhoA fusions either could not be properly constructed (residue 149)
or did not produce a readily detectable protein on an immunoblot
(residues 157, 249, and 352). Therefore, these could not be considered
in the analysis. It was subsequently determined by sequencing that the
157 and 249 plasmids had a frameshift at the junction and lacked an
insert, respectively. In contrast, no sequence defects could be
detected in the entire bfpE gene or at the
bfpE'::'lacZ junction of the 352 fusion
plasmid. Second, CC118 containing particular
bfpE'::'lacZ fusions grew poorly (data not
shown). Third, the amount of BfpE-LacZ fusion protein was greatly
reduced in fusions located after HS3 (Fig. 3). Fourth, many of the
fusions, especially those located after residue 193, exhibited a
conspicuous band with a mobility similar to that expected for native
-galactosidase (~116 kDa). These bands may signify cytoplasmic
-galactosidase liberated by proteolysis of membrane-associated fusion proteins (23, 27). If so, they could result in
spurious
-galactosidase activities.
LacZ fusions prior to HS1 (at BfpE residues 36, 78, and 115) exhibited
high activities, indicating a cytoplasmic location, as would be
expected from the predicted topology and alkaline phosphatase fusion
results. The activities and expression levels of the remaining
BfpE-LacZ fusions provided a picture of the topology of BfpE that was
not completely consistent with the activities of the BfpE-PhoA fusions.
A fusion at the end of HS1 (residue 139) also exhibited high activity,
suggesting that the LacZ moiety was not transported to the
periplasm as expected. In this fusion, LacZ may prevent the
transport of HS1 across the membrane. LacZ fusions having BfpE
endpoints between HS2 and HS3 had low or moderate activities despite
their expected cytoplasmic location based on the PhoA fusion data. The
BfpE-LacZ fusions between HS3 and HS4 likewise exhibited low activities
or no activity. These also produced low levels of full-length fusion
protein, making their activities difficult to evaluate. LacZ fusions
within and following HS4 (residues 337 and 349) gave moderate and very
high activities. The high activity level of the LacZ fusion at 349 appears to be in conflict with the high activity of the PhoA fusion at
352. We tentatively attribute the substantial
-galactosidase
activity of the bfpE349'::'lacZ fusion to an
active
-galactosidase degradation product (Fig. 3). However, we note
that fusions at 292 though 337 also displayed large amounts of
liberated
-galactosidase yet did not have correspondingly high
activities. This may result from sequence differences in the
degradation products. Overall, the
-galactosidase fusions provided
little useful information to help us determine the topology of BfpE,
while alkaline phosphatase fusions supported a topology similar to that
predicted by sequence analysis, with the exception being the location
of HS4 and the BfpE C terminus in the periplasm.
Analyses of dual-reporter sandwich fusions.
To further analyze
the topology of BfpE, we constructed sandwich fusions, where the
reporter moiety was placed at sites internal to the complete BfpE
protein. This approach can provide a more reliable picture of a
protein's topology than the C-terminal deletion fusion approach,
especially when regions of the protein located both N- and C-terminal
to the reporter enzyme must interact to establish the correct topology
(22, 66). In particular, we wished to use such fusions to
test the hypothesis, suggested by the BfpE-PhoA fusions, that HS3 of
BfpE does not act as a TM domain when HS4 is also present. To make
sandwich fusions in bfpE, we utilized a dual-reporter
cassette containing the fused phoA gene and
lacZ
fragment, which allows both PhoA and LacZ enzyme
activities to be analyzed in the context of a single protein
(1). The cassette was inserted in frame into four
restriction sites unique within the bfpE gene of plasmid
pTEB65. As indicated in Fig. 6, these
insertion sites correspond to regions in BfpE near the N terminus
(BtrI and BspEI), between HS3 and HS4
(EcoO109I), and at the extreme C terminus (AvaI).
Two variants of the EcoO109I construct were also prepared:
one which carried two tandem copies of the dual reporter and one in
which the dual reporter was inserted into a bfpE gene that
lacked sequences encoding the putative TM domain HS3 (codons 210 to
233). The sandwich fusion plasmids were introduced into E. coli TG1. When plated on Red-Gal/BCIP dual indicator medium
(1), TG1 colonies carrying the EcoO109I,
EcoO109I×2, and AvaI insertions exhibited
a blue color 1 day after plating, suggesting a
periplasmic location for the dual reporter. In contrast, colonies carrying the BtrI, BstEI, and
EcoO109I
(210-233) insertions exhibited a purplish red
color that was not detectable the day after plating but was clearly
seen after 1 week of storage at 4°C. This result suggests a
cytoplasmic location for the dual reporter in these constructs. The
sandwich fusion proteins were analyzed for enzyme activity and
expression (Fig. 6). Their enzyme activities were extremely low but
detectable, allowing certain conclusions. The relatively high alkaline
phosphatase and low
-galactosidase activities produced by the
AvaI insertion indicate that the C-terminal portion of the
fusion is periplasmic. The striking reversal in the relative
activities produced by the EcoO109I insertions that occurs
on deletion of HS3 strongly supports a periplasmic location for the
segment between HS3 and HS4 as well. These changes argue that HS3 acts
as a TM segment even in the presence of HS4. The other activities were
too low or inconsistent to yield firm conclusions.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 6.
Analyses of BfpE-dual-reporter sandwich fusion
proteins. The labels indicate restriction sites in the bfpE
gene into which a dual-reporter ('phoA-lacZ ) cassette was
inserted. (A) Activities of sandwich fusion proteins. The BfpE protein
is depicted as in Fig. 4, with the arrows indicating the approximate
point at which the dual reporter is inserted into the protein. Alkaline
phosphatase or -galactosidase enzyme assays were performed on
cultures of E. coli TG1 carrying sandwich fusion plasmids.
The bar graph data represent the mean and standard error values for
three separate experiments, with four (alkaline phosphatase) or three
( -galactosidase) enzyme activity determinations per experiment. (B)
Expression of sandwich fusion proteins. Whole-cell extracts were
prepared from the strains described above and separated by SDS-PAGE on
a 6% polyacrylamide gel. The fusion proteins were detected with an
anti-PhoA antibody. The first three lanes display samples from strains
carrying control plasmids, while the remaining lanes display samples
from strains carrying sandwich fusions.
|
|
HS4 can act as a TM segment.
The substantial alkaline
phosphatase activities produced by fusions of PhoA on either side of
HS4 called into question the ability of this region to act as a TM
segment in BfpE. To explore this issue further, we analyzed three
bfpE'::'phoA constructs containing specific
deletions within the bfpE gene (Fig. 4). In the first
construct, sequences encoding HS3 (codons 210 to 233) were deleted from
an otherwise full-length fusion of bfpE to phoA. This construct produced a weakly detectable protein (Fig. 6) that had
moderately high activity (Fig. 4). As a control, a partial bfpE gene ending before the sequence encoding HS4 (at codon
292) and lacking sequences encoding HS3 was fused to phoA.
The construct expressed a readily detectable protein (Fig. 5), but, in
contrast to both the first construct and the C-terminal PhoA fusion at 292, it had no activity (Fig. 4). These data reconfirm the
membrane-spanning capabilities of HS3 and, more importantly, suggest
that HS4 can also act as a TM segment, exporting PhoA to the
periplasm in the absence of HS3. To confirm this notion, a third
phoA fusion construct was analyzed which contained a
bfpE gene from which codons 116 through 301 had been
deleted. The resulting fusion protein lacked hydrophobic segments HS1,
HS2, and HS3, leaving HS4 as the only potential TM segment. This fusion
construct produced a readily detectable protein with considerable PhoA
activity (Fig. 4 and 5), clearly demonstrating that HS4 is capable of
spanning the membrane. The limitation of these constructs was that HS4
was in an orientation opposite from the one it would be expected to hold in the native BfpE protein.
To further probe the ability of HS4 to act as a TM segment, we
constructed three plasmids expressing epitope-tagged BfpE derivatives regulated by an arabinose-inducible promoter. One construct was a
full-length epitope-tagged version of BfpE to be used as a control. A
second construct contained only the region between HS3 and HS4 (residues 234 to 323), while a third contained the entire region of
BfpE downstream of HS3 (residues 234 to 352). The last two constructs
also carried an N-terminal phage fd gene III signal sequence to direct
the expressed proteins to the periplasm, where the inter-HS3/HS4
region appears to be located in full-length BfpE. We used isopycnic
sucrose density flotation gradient fractionation to indicate the
location of the three constructs after expression in the E. coli strain TOP10. Whole-cell lysates were placed at the bottom of
sucrose gradients and subjected to ultracentrifugation. Fractions were
removed sequentially from the top of the gradient and subjected to
electrophoresis followed by immunoblotting with an antibody recognizing
the epitope tag. The protein composition of the fractions was shown to
vary by Ponceau S staining of immunoblotting membranes, with
an increasing number of proteins present near the bottom of the
gradients, as expected for fractions containing the cytoplasmic and
periplasmic contents of the cell (data not shown). We expected the
full-length BfpE construct (residues 1 to 352) to localize to the inner
membrane. Consistent with this notion, this protein appeared primarily
in the less dense fractions of the gradient, the expected location for
inner membrane vesicles (Fig. 7). We
expected the BfpE segment from residues 234 to 323 to be soluble and
periplasmic and to appear near the bottom of the gradient. In
practice, this construct was present in samples from both the middle
and bottom of the gradient but scarce in the lowest-density fractions.
The location of this protein in the middle of the gradient, which
characteristically contains outer membrane vesicles, was surprising. It
may suggest that the protein sequence has some ability to associate
with the outer membrane, a result that is consistent with localization
predictions using the PSORT program (data not shown). The BfpE segment
from residues 234 to 352 would be expected to localize in either the periplasm or inner membrane depending on the transmembrane
properties of HS4. Experimentally, this protein was found primarily in
the least dense fractions of the gradient, indicating an inner membrane location. The striking difference between the gradient distributions of
the constructs containing residues 234 to 323 and 234 to 352 indicates
that HS4 can mediate localization to the cytoplasmic membrane from the
periplasmic side.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 7.
Sucrose density flotation gradient fractionation of
three epitope-tagged BfpE derivatives. (A) Representations of
epitope-tagged BfpE constructs. Each construct carries a C-terminal
myc-His double epitope tag (not shown). For each construct,
the number in the left column indicates the range of BfpE amino acids
that are present. The middle column shows a linear representation of
each protein. The right column displays the expected topology of each
protein. Black boxes and cylinders indicate TM segments, while white
boxes and cylinders indicate an exogenous N-terminal signal sequence,
whose presumed removal is indicated by an arrow. (B) Lysates of TOP10
E. coli carrying plasmids producing the constructs shown in
panel A were fractionated on sucrose density flotation gradients by
centrifugation. Fractions were collected from the top (least dense
portion) of the gradient, separated by SDS-PAGE on a 15%
polyacrylamide gel, and subjected to immunoblotting using an antiserum
recognizing the epitope tag. Fractions progress from the least dense on
the left to the most dense on the right.
|
|
Complementation studies indicate the importance of HS3 and HS4 in
the activity of BfpE.
To determine the extent of the BfpE C
terminus that is required for activity, we tested the longest BfpE-PhoA
fusions for the ability to restore autoaggregation to the
bfpE mutant EPEC strain UMD934. Both the full-length
bfpE352::'phoA fusion and the
bfpE349'::'phoA fusion enabled UMD934 to form
microscopic aggregates, with the aggregates being consistently larger
and more numerous in the bfpE352::'phoA
sample. In contrast, PhoA C-terminal fusions at BfpE residues 337, 323, 320, or 292 did not promote autoaggregation. These results indicate
that an intact HS4 is required for the activity of BfpE. We note that
it is unclear whether the intact BfpE-PhoA fusion or the BfpE portion
remaining after the release of the PhoA moiety (see above) is the
complementing protein in these experiments.
Plasmid pTEB65, which carries the full-length bfpE gene, was
able to restore the ability of UMD934 to autoaggregate. The
HS3 derivative of pTEB65 did not do so, indicating the requirement of HS3
for the function of BfpE. Derivatives of pTEB65 carrying insertions of
the phoA-lacZ
dual reporter at the BtrI,
BstEI, or EcoO109I site of bfpE were
also unable to promote autoaggregation, indicating that the presence of
the reporter moiety at these locations inhibits BfpE function. Of
note, plasmids carrying dual-reporter insertions in the
EcoO109I site of pTEB65, when present in EPEC strain
UMD934, produced dark blue colonies on medium containing BCIP. Plasmids
carrying reporter insertions in the BtrI or
BspEI sites of pTEB65 or in the EcoO109I
site of the
HS3 derivative of pTEB65 did not produce blue
colonies. These observations support the notion that the
topology of BfpE expressed in EPEC is the same as when expressed in
laboratory strains of E. coli.
 |
DISCUSSION |
BfpE is required for BFP biogenesis.
The biogenesis of type IV
fimbriae requires multiple protein components in addition to
pilin, the fimbrial structural element. It is likely that in EPEC, many
or all of the products of the bfp gene cluster constitute a
molecular machine that assembles BFP fimbriae and extrudes them through
the outer bacterial membrane. Other type IV fimbriae are presumably
assembled by similar machines. In this study, we have demonstrated the
requirement for BfpE, one component of the BFP assembly apparatus. We
found that a bfpE mutant strain of EPEC fails to form
detectable BFP and fails to carry out autoaggregation and localized
adherence. The cloned bfpE gene, transcribed from a
heterologous promoter on a low-copy plasmid, complements each of the
defects of the mutant. These results indicate that the BfpE protein is
essential for type IV fimbrial biogenesis in EPEC. The bfpE
mutation does not alter the expression or leader peptide processing of
prebundlin. Since catalysis of disulfide bond formation in bundlin by
the periplasmic protein DsbA is required for pilin stability
(74), BfpE probably participates in an aspect of BFP
synthesis that takes place after the insertion of bundlin into the
cytoplasmic membrane. For example, it may mediate the extraction of
bundlin from the membrane, the polymerization of bundlin into BFP, the
extrusion of BFP through the outer membrane, or the anchoring of BFP to
the cell envelope. BfpE could associate with bundlin directly or could
influence it indirectly through other components of the BFP synthesis
machinery. Mutations introduced into many of the bfp genes,
including bfpB, bfpC, bfpD, bfpG, and bfpL,
elicit phenotypes identical to those found in the bfpE
mutant (4, 6, 49, 58, 60). To understand the specific
requirement for the products of each of these bfp genes in
detail, it will be necessary to develop new means of examining BFP
synthesis at the molecular level.
The phenotypes elicited by the bfpE mutation in EPEC are
quite similar to those created by mutations in the corresponding genes
of other type IV fimbrial systems. Insertion mutations in the
pilC genes of Pseudomonas aeruginosa (34,
45) and Myxococcus xanthus (71), the
pilG genes of Neisseria gonorrhoeae and
Neisseria meningitidis (62), the
pilR gene of the R64 plasmid (72), and the
tcpE gene of Vibrio cholerae (9, 32)
all generate strains that fail to elaborate functional type IV
fimbriae. When tested, some of these mutants have been shown to exhibit
normal levels of processed pilin, as does our bfpE mutant.
Mutations in other genes of the gspF family disable protein
secretion by the type II pathway present in particular gram-negative
bacteria (15, 36, 47, 55) or reduce genetic transformation
competence (i.e., binding and uptake of exogenous DNA) in some
gram-negative and gram-positive bacteria (11, 62). It
appears that intact GspF proteins are universally required for the
operation of the molecular machines of which they are a component.
Topology of BfpE.
As a further step toward understanding the
structure and function of BfpE and other GspF proteins, we have
determined the arrangement of BfpE in the cytoplasmic membrane. For
this purpose we isolated and constructed fusions of 3'-truncated
bfpE derivatives to phoA (alkaline phosphatase)
and lacZ (
-galactosidase) genes. These had a wide range
of BfpE endpoints, covering each of the hydrophilic domains of the
protein. We also constructed a small number of sandwich fusions. The
ability to identify both active and inactive PhoA and LacZ fusions
strongly supports the notion that BfpE is a cytoplasmic membrane
protein, as do the results of sucrose density gradient centrifugation
with an epitope-tagged version of BfpE. A study of the relative
activities and levels of the fusion proteins allowed us to evaluate the
locations and orientations of four putative TM segments, HS1 through
HS4, identified through sequence analysis. The activities of the
BfpE-PhoA fusion proteins, as well as the dual-reporter sandwich
fusions, varied in a manner consistent with the topology shown in Fig.
8. This topology meets the criteria of
the positive-inside rule (67), with the majority of the
arginine and lysine residues being located in the cytoplasm. The region
between HS3 and HS4 contains 12 such residues and is periplasmic
but can be considered exempt from the rule due to its length of greater
than 60 residues (69, 70). Overall, the BfpE protein can
be thought of as being divided into thirds. The N-terminal third is
located in the cytoplasm. The middle third serves as a membrane anchor,
containing three membrane-spanning segments. The C-terminal third is
located primarily in the periplasm, with its end anchored in the
membrane. As discussed in more detail below, this organization has
profound implications for the function of BfpE.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 8.
Proposed topology of the BfpE protein. The amino acids
composing BfpE are represented by circles. These are displayed in a
manner that specifies their arrangement in the E. coli
cytoplasmic membrane. HS1 through HS4 denote TM segments. Positively
charged amino acids (arginines and lysines) that may be topology
determinants are shaded. C-terminal fusion protein junctions are
indicated by a line and the number of the terminal BfpE residue in the
fusion. The insertion sites for the dual reporter in sandwich fusions
are indicated by a restriction enzyme name.
|
|
We obtained conflicting data on the location of HS4, the fourth
putative TM segment in BfpE. When PhoA was fused to BfpE that had been
truncated on either side of HS4, substantial alkaline phosphatase
activities resulted, suggesting that HS4 remains in the periplasm
instead of inserting into the membrane. This finding was unexpected,
since all computer programs had predicted HS4 to be a TM domain.
Furthermore, the activities of bfpE::phoA
internal deletion constructs and the results of isopycnic sucrose
gradient experiments using partial BfpE proteins indicated that HS4 is capable of spanning the membrane, at least as an isolated unit. Given
the conflicting data, it remains somewhat unclear whether HS4 in the
native BfpE protein crosses the membrane. We favor a model in which HS4
is a stop-transfer sequence that normally inserts into the membrane but
is prevented from doing so in our fusions by the PhoA reporter, which
prefers to reside in the periplasm. This model is most consistent
with our data showing that HS4 is able to cross the membrane in either
direction. The short (10-residue) segment following HS4 contains only
one positive charge, which may be insufficient to retain the PhoA
moiety in the cytoplasm. This situation would be analogous to that of
the PhoA fusions at residues 190 and 193 of BfpE. These fusions are
anchored by few positive charges and have alkaline phosphatase
activity, although located in a region that is cytoplasmic in the
full-length protein. We cannot entirely exclude the explanation that
HS4 actually does not insert into the membrane, perhaps being prevented
from doing so by other topological determinants in BfpE. A final
possibility is that the topology of the HS4 region is variable,
reflecting some ability of the protein to undergo conformation changes
while in the membrane. Such a property has been demonstrated for SecG, a component of the E. coli preprotein translocase
(44). Given the current data, the placement of HS4 in the
membrane must be regarded as provisional.
BfpE has a different topology from another GspF protein.
The
topology of OutF, a GspF protein from the type II protein secretion
system of Erwinia carotovora, was previously determined using
-lactamase gene fusions (61). Like BfpE, OutF has
a large N-terminal cytoplasmic segment plus TM domains that are analogs of HS1 and HS2. However, the C-terminal portion of the OutF topology is
surprisingly divergent from that proposed here for BfpE. A TM domain
corresponding to HS3 does not exist in OutF. As a result, most of the
C-terminal third of OutF is located in the cytoplasm while the
C-terminal third of BfpE is found mostly in the periplasm. The
third TM segment in OutF is analogous to HS4 of BfpE in terms of its
position in the protein sequence. However, in OutF this segment crosses
the membrane from the cytoplasmic to the periplasmic side, while in
BfpE it appears to have the opposite orientation. The topologies of the
two proteins could be identical if HS3 of BfpE was excluded from
crossing the membrane in the presence but not in the absence of HS4.
However, this possibility was ruled out by BfpE sandwich fusion data,
which indicate that the region downstream of HS3 is located in the
periplasm even when HS4 is present. In summary, the presence of HS3
and disposition of HS4 define the differences between BfpE and OutF.
It is important to understand whether the differences in the
experimentally determined membrane topologies of BfpE and OutF reflect
the actual topologies of the native proteins or indicate artifacts
introduced by the use of fusion proteins. In theory, the presence of
the reporter protein could alter the topology of specific fusions.
However, such effects are not been generally noted for PhoA, LacZ, or
BlaM fusions (64). It is also possible that the BfpE
fusion proteins could acquire an incorrect topology in the absence of
other Bfp proteins in the E. coli K-12 strains used in this
study. However, individual membrane proteins are thought to integrate
into the membrane independently of one another (46, 48, 63,
73). Furthermore, the BfpE sandwich fusions appeared to have the
same topology in EPEC and K-12 E. coli based on a
chromogenic indicator assay, and the topology of OutF in the context of
wild-type Erwinia did not differ from that deduced in
an E. coli host that lacks a functional
general secretion pathway (61). Thus, it appears
that OutF and BfpE, although members of the same protein family, have
dramatically different membrane topologies. These topologies are
presumably adapted to the protein export machinery of
Erwinia and the pilus biogenesis machinery of EPEC and may
reflect interactions that occur with protein components unique to each
respective system.
To suggest the extent to which the BfpE or OutF topologies prevail in
the GspF family, we used TMHMM (59) to analyze the sequences of various GspF proteins (data not shown). This algorithm was
chosen because its topology predictions for both OutF and BfpE
correspond closely to the experimentally determined topologies. TMHMM
identified three TM segments in each of the GspF proteins tested,
located approximately at the same positions as those in OutF. Each of
the predicted topologies was identical to that of OutF. A significantly
hydrophobic segment corresponding to HS3 of BfpE was not identified in
any of the other GspF proteins. Notably, such a segment was not present
in the two proteins that are most similar in sequence to BfpE. These
proteins are TcpE, encoded by the toxin-coregulated pilus gene cluster
of V. cholerae (32), and PilR, encoded by the
thin pilus gene cluster of the IncI plasmid R64 (72). Thus
far, OutF appears to be structurally representative of the GspF family
while the topology of BfpE appears to be novel.
An understanding of the membrane topology of BfpE provided by the
results of this study should allow us to construct testable models of
protein interactions integral to the BFP biogenesis machinery.
With its large N-terminal cytoplasmic domain and large C-terminal periplasmic domain, BfpE appears poised to bridge the gap between components in multiple compartments. Because the N terminus
of BfpE has a cytoplasmic location conserved with the other GspF
proteins, it may retain a conserved function. The C terminus of BfpE,
with its unique periplasmic location, may have a more specialized function.
In addition to the specific information provided regarding the topology
of BfpE, several general points are emphasized by the results of this
study. First, the results obtained by analyzing the enzymatic activity
of a single type of reporter protein can convey misleading data.
Second, the use of complementary systems can lead to conflicting data.
To reconcile these data, it is important to analyze additional
information such as the steady-state levels of the fusion proteins and
the activities of fusion proteins generated by deletions of TM domains
or sandwich fusions. Lastly, the topology of one member of a protein
family (such as BfpE) cannot always be inferred from the analysis of
another member of that family (such as OutF) but must be determined by experimentation.
We thank Ravi Anantha for providing strain UMD932, Colin Manoil
for providing strain CC118, Mikhail Alexeyev for providing plasmid
pMA632 and strain TG1, John Albert and Jorge Girón for providing
monoclonal antibody ICA4, David Silverman for the use of his
fluorescence spectrophotometer, and Harry Mobley and Shanmuga Sozhamannan for helpful comments on the manuscript. We are grateful to
members of the Donnenberg laboratory for helpful suggestions during the
course of this work, especially Ravi Anantha, and Barry McNamara, who
identified the optimal conditions for autoaggregation.
This investigation was supported by a Public Health Service grant (R01
AI-37606) to M.S.D. and a National Research Service Award postdoctoral
training fellowship (F32 AI-10191) to T.E.B.